Latest News - Page 3

The Prevalence of Cirrhosis in Patients with Hepatitis C Is Growing
BY CAITLYN FITZPATRICK
Patients unaware of their HCV infection just as likely to have cirrhosis as those who knew about their infection.
FDA Approves New Hepatitis C Therapy
BY DAVY JAMES, MANAGING EDITOR
Zepatier is a once-daily, fixed-dose combination containing with the NS5A inhibitor elbasvir and the NS3/4A protease inhibitor grazoprevir.
Dialysis Providers Should Improve Infection Control to Stop Spread of HCV, CDC Says
BY AMY JACOB
Lapses in dialysis care could undoubtedly expose patients to HCV.
Most Children Born to Hepatitis C-Positive Mothers Don't Get Tested
BY CAITLYN FITZPATRICK
Study finds HCV screening of pregnant women and their children needs to be improved.
Recurrence of Hepatitis C After Treatment Varies Among Subgroups
BY CATHERINE KOLONKO
Patients with HCV maintained SVR after treatment, but researchers find higher reinfection risk among patients in two subgroups.
First Sub-Licences Signed for Hepatitis C Drug Daclatasvir
BY LAUREN SANTYE, ASSISTANT EDITOR
HCV treatment has been shown to cure up to 100% of patients depending on genotype and stage of liver disease.
HIV Coinfection Doesn't Affect Hep C Treatment Adherence
BY JEANNETTE Y. WICK, RPH, MBA, FASCP
Patients who do not have HIV and adhere to their prescribed regimens usually have undetectable HCV RNA after 12 weeks of therapy.
International Liver Cancer Treatment Guidelines too Restrictive
BY LAUREN SANTYE, ASSISTANT EDITOR
Restrictions concerning given high number of undiagnosed hepatitis C cases worldwide.
$auto_registration$